Gilead Sciences Inc. has officially announced the appointment of Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance. In this new capacity, she will report directly to Chairman and CEO Daniel O’Day and join the company’s strategic senior leadership team.
career trajectory and key contributions Wettan brings 14 years of experience within Gilead, having held progressively senior legal leadership roles. Most recently, she served as Senior Vice President leading the Global Legal Business Partners team.
Notable milestones during her tenure at the corporation include:
- Commercialization support: Playing an instrumental role in launching new medications, including a breakthrough twice-yearly HIV prevention medicine.
- Strategic governance: Previously leading teams focused on litigation, government investigations, corporate governance, and strategic transactions.
- Community engagement: She currently serves as the Chair of the Board of the Gilead Foundation.
professional background and leadership vision Prior to her career in the pharmaceutical industry, Wettan was an attorney at a prominent law firm in New York City, specializing in general litigation and government investigations. She earned her Juris Doctor (J.D.) from the University of California at Berkeley.
Company leadership noted that Wettan’s deep legal expertise and commitment to the communities they serve will be vital assets as the firm continues to advance its strongest-ever pipeline and pioneer global health access agreements.